Woodline Partners’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.15M Buy
+104,162
New +$7.1M 0.03% 582
2024
Q1
Sell
-173,808
Closed -$6.42M 580
2023
Q4
$6.42M Buy
+173,808
New +$6.55M 0.07% 286
2023
Q3
Sell
-346,555
Closed -$12.5M 655
2023
Q2
$12.5M Buy
+346,555
New +$11.8M 0.15% 180

Other funds holding HALO

Woodline Partners's HALO Position: Q2 2026 in Review

Woodline Partners opened a new position in Halozyme (HALO) in Q2 2026: 104,162 shares worth $8.15M. The stake represents 0.03% of the portfolio and ranks #582 among its holdings. This is a return to the name: Woodline Partners previously reported a position in HALO as recently as Q4 2023.

Woodline Partners first reported a position in HALO in Q2 2023 and has held it in 3 quarters since. The position peaked at $12.5M in Q2 2023. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Woodline Partners held 104,162 shares of Halozyme worth $8.15M as of Q2 2026.
  • Halozyme was a new Woodline Partners position in Q2 2026.
  • Halozyme made up 0.03% of Woodline Partners's portfolio in Q2 2026, its #582 holding.
  • Woodline Partners first reported a position in Halozyme in Q2 2023 and has held it in 3 quarters since.
  • Woodline Partners's Halozyme position peaked at $12.5M in Q2 2023.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.